Palo Alto Investors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
|
|||||
|
2025
Q1 | $1.21M | Sell |
|
|||||
|
2024
Q4 | $3.32M | Sell |
|
|||||
|
2024
Q3 | $4.23M | Hold |
|
|||||
|
2024
Q2 | $4.43M | Hold |
|
|||||
|
2024
Q1 | $7.7M | Hold |
|
|||||
|
2023
Q4 | $4.41M | Sell |
|
|||||
|
2023
Q3 | $7.61M | Hold |
|
|||||
|
2023
Q2 | $10.2M | Hold |
|
|||||
|
2023
Q1 | $22.1M | Buy |
|
|||||
|
2022
Q4 | $19.2M | Buy |
|
|||||
|
2022
Q3 | $30.7M | Hold |
|
|||||
|
2022
Q2 | $25.4M | Hold |
|
|||||
|
2022
Q1 | $41.4M | Buy |
|
|||||
|
2021
Q4 | $35.2M | Buy |
|
|||||
|
2021
Q3 | $31.3M | Hold |
|
|||||
|
2021
Q2 | $55.6M | Buy |
|
|||||
|
2021
Q1 | $56.4M | Buy |
|
|||||
|
2020
Q4 | $81.5M | Buy |
|
|||||
|
2020
Q3 | $74.3M | Buy |
|
|||||
|
2020
Q2 | $79.9M | Sell |
|
|||||
|
2020
Q1 | $82.6M | Sell |
|
|||||
|
2019
Q4 | $88.1M | Sell |
|
|||||
|
2019
Q3 | $46.6M | Sell |
|
|||||
|
2019
Q2 | $31.5M | Hold |
|
|||||
|
2019
Q1 | $30.7M | Buy |
|
|||||
|
2018
Q4 | $43.9M | Buy |
|
|||||
|
2018
Q3 | $79.4M | Hold |
|
|||||
|
2018
Q2 | $79.2M | Buy |
|
|||||
|
2018
Q1 | $49.4M | Buy |
|
|||||
|
2017
Q4 | $34M | Buy |
|
|||||
|
2017
Q3 | $38.4M | Buy |
|
|||||
|
2017
Q2 | $31.4M | Buy |
|
|||||
|
2017
Q1 | $43.7M | Buy |
|
|||||
|
2016
Q4 | $30.1M | Buy |
|
|||||
|
2016
Q3 | $30M | Sell |
|
|||||
|
2016
Q2 | $21.1M | Buy |
|
|||||
|
2016
Q1 | $27.6M | Sell |
|
|||||
|
2015
Q4 | $41.2M | Buy |
|
|||||
|
2015
Q3 | $32.5M | Buy |
|
|||||
|
2015
Q2 | $47.1M | Buy |
|
|||||
|
2015
Q1 | $29.1M | Buy |
|